Headline Expenditure Projections
* Pharmaceuticals:
* Healthcare:
* Medical devices: MYR3.51bn (US$1.09bn) in 2010 to MYR3.74bn (US$1.25bn) in 2011; +6.7% in local currency terms and +14.3% in US dollar terms. Forecast down marginally from Q211 due to macroeconomic factors.
------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/
------------------------------------------------------------
Business Environment Rating: Malaysia is ranked eighth in the Asia Pacific region. Its rating of 59.6 suggests an operating environment that poses some risks to multinationals, yet offers a respectable long-term prospect in the Asian region.
Key Trends & Developments
* In April 2011, Malaysia introduced a new service of sending prescribed medicines by post. This service caters for patients who need to consume pharmaceuticals on a continuous basis. This means that registered patients do not have to wait at hospitals, clinics or pharmacies.
* In line with Malaysia's growing importance as an R&D and clinical trials centre, in April 2011, global clinical research organisation (CRO), SIRO Clinpharma launched operations in Malaysia as part of its strategy to expand its presence in Asia.
BMI Economic View: Malaysia's real GDP growth came in at a weaker-than-
BMI Political View: Although the US-Malaysia Free Trade Agreement (FTA) appears to have stalled since 2010, talks on an agreement with the EU seem to be progressing. Under the agreement, prices of medicines are expected to increase, as pharmaceutical companies' patent rights would be extended from the present 15 years to 20 years.
Partial Table of Contents:
SWOT Analysis
- Malaysia Pharmaceuticals And Healthcare Industry SWOT
- Malaysia Political SWOT
- Malaysia Economic SWOT
- Malaysia Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q311
- Rewards
- Risks
Malaysia - Market Summary
Regulatory Regime
- Bioequivalence
- Pharmaceutical And Medical Advertising
- Labelling Requirements
- Recent Regulatory Developments
- Intellectual Property Regime
- Counterfeit Pharmaceuticals
- Compulsory Licensing
- Free Trade Agreements
- Pricing And Reimbursement
Industry Trends And Developments
- Epidemiology
- Table: 10 Leading Causes Of Death In Ministry of Health Hospitals, 2005
- Non-Communicable Disease
- Communicable Disease
- Healthcare Sector
- Healthcare Sector Funding
- Medical Tourism
- Biotechnology And Research
- Table: Key Points Of The Malaysian National Biotechnology Policy
- Table: The Benefits Of Conducting Biotechnology Research In Malaysia
- Recent Biotechnology Developments
- Clinical Trials
- Recent Developments in the Clinical Trials Industry
- Medical Devices
- Leading Medical Device Players
- Recent Developments In The Medical Devices Industry
Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic
- Table: Malaysia - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2007-2015
- Other Healthcare Data Forecasts
- Key Risks To BMI's Forecast Scenario
Competitive Landscape Analysis
- Domestic Pharmaceutical Industry
- Foreign Pharmaceutical Industry
- Pharmaceutical Demand
- Recent Company Activities
- Table: Leading Malaysian Pharmaceutical And Healthcare Companies
- Halal Medicine
- Traditional Medicine
- Pharmaceutical Distribution
Company Profiles
- Leading Domestic Manufacturers
- Pharmaniaga
- Prime Pharmaceutical
- Bumimedic Sdn. Bhd.
- Hovid
- Chemical Company of Malaysia (CCM)
- Kotra Pharma
- Multinational Companies
- GlaxoSmithKline (GSK)
- Pfizer
- Novartis
- Merck & Co
- Sanofi-Aventis
- Ranbaxy Malaysia
Country Snapshot: Malaysia Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
-
Full Table of Contents is available at:
-- http://www.fastmr.com/
About Business Monitor International
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
# # #
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
